{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=In+Person&page=45", "query": { "intervention": "In Person", "page": 45 }, "page_size": 10 }, "pagination": { "page": 45, "page_size": 10, "total_count": 10017, "total_pages": 1002, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=In+Person&page=46&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=In+Person&page=44&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-30T13:26:23.173Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04930965", "title": "Impact of LA-CEAL HALT COVID-19 Ambassador Program on Likelihood to Vaccinate", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Covid19", "Vaccine Refusal" ], "interventions": [ { "name": "Community health worker engagement", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Tulane University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 56, "start_date": "2021-10-05", "completion_date": "2023-02-28", "has_results": true, "last_update_posted_date": "2024-01-18", "last_synced_at": "2026-10-30T13:26:23.173Z", "location_count": 1, "location_summary": "New Orleans, Louisiana", "locations": [ { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT04930965" }, { "nct_id": "NCT05293730", "title": "Trial of the Impact of the Electronic Frailty Integrated With Social Needs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Aging" ], "interventions": [ { "name": "eFRIEND", "type": "BEHAVIORAL" }, { "name": "Usual Care", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 2050, "start_date": "2022-09-06", "completion_date": "2024-05-12", "has_results": false, "last_update_posted_date": "2024-07-03", "last_synced_at": "2026-10-30T13:26:23.173Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05293730" }, { "nct_id": "NCT03399500", "title": "Homeless Care Management App", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Substance Use Disorders", "Mental Health Impairment", "Health Behavior", "Adherence, Patient" ], "interventions": [ { "name": "In-Person Case Management at Homeless Recovery Program", "type": "BEHAVIORAL" }, { "name": "Unlimited Smartphone", "type": "BEHAVIORAL" }, { "name": "Smartphone Based Case Management (SPCM) app", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Oklahoma", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 403, "start_date": "2018-04-27", "completion_date": "2023-11-14", "has_results": true, "last_update_posted_date": "2024-12-19", "last_synced_at": "2026-10-30T13:26:23.173Z", "location_count": 2, "location_summary": "Oklahoma City, Oklahoma • Dallas, Texas", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03399500" }, { "nct_id": "NCT03896711", "title": "MEMORI Corps: Activity-based Companion Care for Dementia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alzheimer Disease", "Dementia" ], "interventions": [ { "name": "MEMORI Corps program", "type": "BEHAVIORAL" }, { "name": "Augmented Waitlist Control", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "115 Years", "sex": "ALL", "summary": "18 Years to 115 Years" }, "enrollment_count": 175, "start_date": "2022-03-01", "completion_date": "2025-05-31", "has_results": true, "last_update_posted_date": "2026-01-28", "last_synced_at": "2026-10-30T13:26:23.173Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03896711" }, { "nct_id": "NCT07663422", "title": "Mycophenolate Mofetil w/ Prednisone for Immune Related Hepatitis From Checkpoint Inhibitor Therapy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Immune-mediated Hepatitis", "Immune-related Adverse Event" ], "interventions": [ { "name": "Mycophenolate Mofetil plus prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fox Chase Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 31, "start_date": "2026-07-23", "completion_date": "2028-09-30", "has_results": false, "last_update_posted_date": "2026-09-17", "last_synced_at": "2026-10-30T13:26:23.173Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07663422" }, { "nct_id": "NCT00896051", "title": "TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV Infections", "Acquired Immunodeficiency Syndrome" ], "interventions": [ { "name": "Atazanavir (ATV) 300 mg", "type": "DRUG" }, { "name": "Atazanavir (ATV) 400 mg", "type": "DRUG" }, { "name": "Ritonavir (rtv) 100 mg", "type": "DRUG" }, { "name": "Nucleo(side)/(tide) reverse transcriptase inhibitors (NRTIs)", "type": "DRUG" }, { "name": "Etravirine (ETR) 200 mg", "type": "DRUG" }, { "name": "Tenofovir disoproxil fumarate (TDF) 300 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen R&D Ireland", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2009-08", "completion_date": "2012-04", "has_results": true, "last_update_posted_date": "2013-09-30", "last_synced_at": "2026-10-30T13:26:23.173Z", "location_count": 10, "location_summary": "Little Rock, Arkansas • Bakersfield, California • Beverly Hills, California + 7 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bakersfield", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00896051" }, { "nct_id": "NCT03817229", "title": "Epilepsy Adherence in Children and Technology (eACT)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Epilepsy" ], "interventions": [ { "name": "Education microlearning sessions", "type": "BEHAVIORAL" }, { "name": "Automated digital reminders", "type": "BEHAVIORAL" }, { "name": "Problem-solving mHealth module", "type": "BEHAVIORAL" }, { "name": "Individualized Adherence Feedback Report", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "2 Years to 12 Years" }, "enrollment_count": 268, "start_date": "2019-04-15", "completion_date": "2024-08-01", "has_results": true, "last_update_posted_date": "2025-10-30", "last_synced_at": "2026-10-30T13:26:23.173Z", "location_count": 4, "location_summary": "Orange, California • Cincinnati, Ohio • Columbus, Ohio + 1 more", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03817229" }, { "nct_id": "NCT05935631", "title": "Feasibility, Acceptability and Directional Signal Effect on Blood Folate Levels of Iodized Salt Fortified With Folic Acid: Clinical Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Neural Tube Defects", "Folic Acid Deficiency", "Fortification" ], "interventions": [ { "name": "Salt with folic acid and iodine", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "FEMALE", "summary": "18 Years to 40 Years · Female only" }, "enrollment_count": 32, "start_date": "2023-01-24", "completion_date": "2023-06-30", "has_results": false, "last_update_posted_date": "2023-08-01", "last_synced_at": "2026-10-30T13:26:23.173Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT05935631" }, { "nct_id": "NCT05545319", "title": "A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)", "Coronavirus Disease 2019 (COVID-19)", "Immunocompromised", "Hospitalization", "Child, Hospitalized" ], "interventions": [ { "name": "Nirmatrelvir", "type": "DRUG" }, { "name": "Ritonavir", "type": "DRUG" }, { "name": "Placebo for nirmatrelvir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 0, "start_date": "2022-12-13", "completion_date": "2024-01-06", "has_results": false, "last_update_posted_date": "2023-03-01", "last_synced_at": "2026-10-30T13:26:23.173Z", "location_count": 2, "location_summary": "Cooperstown, New York • New York, New York", "locations": [ { "city": "Cooperstown", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05545319" }, { "nct_id": "NCT00194428", "title": "Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Obesity", "Metabolic Syndrome X", "Hyperlipidemia", "Hypertension" ], "interventions": [ { "name": "Almond enriched diet", "type": "BEHAVIORAL" }, { "name": "Low fat caloric diet", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Temple University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 123, "start_date": "2005-02", "completion_date": "2009-10", "has_results": false, "last_update_posted_date": "2013-03-28", "last_synced_at": "2026-10-30T13:26:23.173Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00194428" } ] }